June 25, 2021
During the EHA2021 Virtual Congress, Know AML spoke with Isolda Fernandez, FUNDALEU, Buenos Aires, AR. We asked, Are there any other options to intensive chemotherapy? In this video, Fernandez discusses alternative treatment options to intensive chemotherapy for patients with AML. She talks about the advances in this field, the approval of a novel agent targeting genetic mutations, and the combination of venetoclax with azacitidine for older patients who are not fit for intensive chemotherapy.